Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Equity Average (2021 - 2025)

Lucid Diagnostics' Equity Average history spans 5 years, with the latest figure at $18.4 million for Q4 2025.

  • For Q4 2025, Equity Average rose 213.5% year-over-year to $18.4 million; the TTM value through Dec 2025 reached $18.4 million, up 213.5%, while the annual FY2025 figure was $8.2 million, 430.1% up from the prior year.
  • Equity Average reached $18.4 million in Q4 2025 per LUCD's latest filing, up from $16.8 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $50.6 million in Q1 2022 to a low of -$22.0 million in Q3 2021.
  • Average Equity Average over 5 years is $13.1 million, with a median of $13.9 million recorded in 2024.
  • Peak YoY movement for Equity Average: surged 4687.35% in 2024, then tumbled 99.85% in 2025.
  • A 5-year view of Equity Average shows it stood at $15.3 million in 2021, then skyrocketed by 65.27% to $25.3 million in 2022, then plummeted by 99.52% to $122500.0 in 2023, then soared by 4687.35% to $5.9 million in 2024, then surged by 213.5% to $18.4 million in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Equity Average are $18.4 million (Q4 2025), $16.8 million (Q3 2025), and $1.2 million (Q2 2025).